A Small Molecule p75^NTR Ligand, LM11A-31, Reverses Cholinergic Neurite Dystrophy in Alzheimer's Disease Mouse Models with Mid- to Late-Stage Disease Progression

• Danielle A. Simmons,

  Affiliation Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, United States of America

  ⨯
• Juliet K. Knowles,

  Affiliations Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, United States of America, Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯
• Nadia P. Belichenko,

  Affiliation Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, United States of America

  ⨯
• Gargi Banerjee,

  Affiliation Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, United States of America

  ⨯
• Carly Finkle,

  Affiliation Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, United States of America

  ⨯
• Stephen M. Massa,

  Affiliation Department of Neurology and Laboratory for Computational Neurochemistry and Drug Discovery, San Francisco Veterans Affairs Medical Center, and Department of Neurology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Frank M. Longo

  * E-mail: longo@stanford.edu

  Affiliations Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, United States of America, Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America

  ⨯